Real-World Effectiveness of a Triple Combination BDP/FF/GB Extrafine in a Single Pressurised Metered Dose Inhaler in Brazilian COPD Patients

NCT07406048 · clinicaltrials.gov ↗

RECRUITING

Status

396

Enrollment

INDUSTRY

Sponsor class

Conditions

COPD (Chronic Obstructive Pulmonary Disease)

Interventions

DRUG: BDP/FF/GB (100ug/6ug/12.5ug)

Sponsor

Chiesi Farmaceutica Ltda.